Continue to Site

Medbio acquires Polymer Conversions

September 2, 2020 By Chris Newmarker

Medtech contract manufacturer Medbio (Grand Rapids, Mich.) announced today that it has acquired Orchard Park, N.Y.–based Polymer Conversions.

The financial terms of the deal were not disclosed.

Polymer Conversions is a full-service medical device contract manufacturer that specializes in complex thermoplastic injection molding and value-add assembly. Its offerings complement Medbio, which specializes in cleanroom injection molding of plastic components for the medical and biotechnology industries.

“I’m looking forward to partnering with the PCI team to expand Medbio’s manufacturing capabilities, while reaching new customers and end markets,” Medbio CEO Chris Williams said in a news release.

Medbio is a portfolio company of Graham Partners, a private investment firm with a specialty in industrial technology and advanced manufacturing companies.

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.